Activated protein C sensitivity ratio in pregnant women at delivery

British Journal of Haematology

Volumn 92, Issue 1, 1996, Pages 244-246

  Mathonnet, Florence ^a   De Mazancourt, Philippe ^a   Bastenaire, Brigitte ^b   Morot, Mireille ^a   Benattar, Norbert ^c   Beufé, Sylvie ^d   Borg, Jeanne Yvonne ^d   Giudicelli, Yves ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b CTS des Yvelines   (France)

^c Biogenic   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Blood coagulation disorders; Factor V; Factor VIII; Pregnancy; Protein C

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; ORAL CONTRACEPTIVE AGENT; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL;

EID: 0030047554     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1995.00271.x     Document Type: Article

References (12)

1. Bertina, R.M., Koeleman, P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., Ronde, H., Van Der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
2. Beufé, S., Borg, J.-Y., Vasse, M., Charbonnier, M., Moreau, V., Monconduit, M. & Frebourg, T. (1995) Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein C. British Journal of Haematology, 89, 659-662.
3. Bick, R.L. & Pegram, M. (1994) Syndroms of hypercoagulability and thrombosis: a review. Seminars in Thrombosis and Hemostasis, 20, 109-132.
4. Comp, P.C., Thurnau, G.R., Welsh, J. & Esmon, C.T. (1986) Functional and immunologic protein S are decreased during pregnancy. Blood, 68, 881-885.
5. Dahlbäck, B. (1995) Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood, 85, 607-614.
6. Dahlbäck, B., Carlsson, M. & Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognized mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004-1008.
7. Koster, T., Rosendaal, F.R., de Ronde, H., Briet, E., Vandenbroucke, J.P. & Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet, 342, 1503-1506.
8. Østerud, B., Robertsen, R., Åsvang, G.B. & Thijssen, F. (1994) Resistance to activated protein C is reduced in women using oral contraceptives. Blood Coagulation and Fibrinolysis, 5, 853-854.
9. Rosén, S., Johansson, K., Lindberg, K. & Dahlbäck, B. (1994) Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals. Thrombosis and Haemostasis, 72, 255-260.
10. Stirling, Y., Woolf, L., North, W.R.S., Seghatchian, M.J. & Meade, T.W. (1984) Haemostasis in normal pregnancy. Thrombosis and Haemostasis, 52, 176-182.
11. Vandenbroucke, J.P., Koster, T., Briët, E., Reitsma, P.H., Bertina, R.M. & Rosendaal, F.R. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet. 344, 1453-1457.
12. Vasse, M., Leduc, O., Borg, J.Y., Chrétien, M.H. & Monconduit, M. (1994) Resistance to activated protein C: evaluation of three functional assays. Thrombosis Research, 76, 47-59.